Mercedes Rincon
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-6 | 17 | 2025 | 784 | 3.250 |
Why?
| | Mitochondria | 11 | 2026 | 997 | 2.610 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 10 | 2018 | 263 | 2.120 |
Why?
| | Glycogen Synthase Kinase 3 beta | 6 | 2025 | 74 | 1.800 |
Why?
| | Mitochondrial Proteins | 7 | 2026 | 263 | 1.770 |
Why?
| | STAT3 Transcription Factor | 5 | 2025 | 214 | 1.640 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2025 | 931 | 1.450 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2025 | 1150 | 1.360 |
Why?
| | Molecular Chaperones | 3 | 2020 | 200 | 1.300 |
Why?
| | HSP40 Heat-Shock Proteins | 4 | 2023 | 26 | 1.220 |
Why?
| | Interleukins | 5 | 2016 | 248 | 1.050 |
Why?
| | Thymocytes | 2 | 2025 | 33 | 0.880 |
Why?
| | Inflammation | 11 | 2026 | 2919 | 0.880 |
Why?
| | Receptors, Interleukin-6 | 4 | 2013 | 49 | 0.800 |
Why?
| | Orthomyxoviridae Infections | 4 | 2025 | 72 | 0.790 |
Why?
| | Mice | 45 | 2026 | 18297 | 0.780 |
Why?
| | Animals | 55 | 2026 | 38106 | 0.770 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2025 | 330 | 0.760 |
Why?
| | Adenosine Triphosphate | 3 | 2021 | 494 | 0.730 |
Why?
| | Lymphocyte Activation | 9 | 2025 | 1137 | 0.690 |
Why?
| | Phosphoserine | 2 | 2020 | 25 | 0.680 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2021 | 117 | 0.630 |
Why?
| | MAP Kinase Signaling System | 5 | 2014 | 307 | 0.630 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 356 | 0.620 |
Why?
| | Mice, Inbred C57BL | 22 | 2025 | 6034 | 0.610 |
Why?
| | Cell Respiration | 4 | 2024 | 104 | 0.580 |
Why?
| | Electron Transport Complex I | 2 | 2023 | 42 | 0.570 |
Why?
| | Asthma | 5 | 2020 | 1800 | 0.540 |
Why?
| | Allergens | 3 | 2020 | 390 | 0.530 |
Why?
| | Orthomyxoviridae | 2 | 2016 | 41 | 0.530 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 265 | 0.500 |
Why?
| | Fatty Acids | 1 | 2020 | 460 | 0.490 |
Why?
| | Cell Movement | 1 | 2021 | 951 | 0.490 |
Why?
| | Aspergillus fumigatus | 4 | 2011 | 26 | 0.490 |
Why?
| | Lymphocytes | 2 | 2018 | 379 | 0.490 |
Why?
| | Eosinophils | 3 | 2020 | 319 | 0.490 |
Why?
| | Cell Differentiation | 7 | 2021 | 1982 | 0.490 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2016 | 15 | 0.480 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.480 |
Why?
| | Neoplasms | 4 | 2026 | 2954 | 0.480 |
Why?
| | B-Lymphocytes | 4 | 2016 | 887 | 0.470 |
Why?
| | Liver | 2 | 2025 | 1864 | 0.460 |
Why?
| | Phosphorylation | 9 | 2025 | 1724 | 0.460 |
Why?
| | Cell Death | 1 | 2017 | 379 | 0.460 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 893 | 0.450 |
Why?
| | Mice, Knockout | 14 | 2025 | 3125 | 0.450 |
Why?
| | Lung | 12 | 2025 | 4122 | 0.450 |
Why?
| | Gene Expression Regulation | 8 | 2018 | 2599 | 0.440 |
Why?
| | Cytokines | 6 | 2021 | 2081 | 0.430 |
Why?
| | Respiratory Hypersensitivity | 3 | 2020 | 65 | 0.420 |
Why?
| | Immunoglobulin G | 3 | 2016 | 901 | 0.420 |
Why?
| | Breast Neoplasms | 4 | 2025 | 2418 | 0.400 |
Why?
| | Behavior, Animal | 1 | 2017 | 531 | 0.400 |
Why?
| | Fear | 1 | 2017 | 373 | 0.400 |
Why?
| | Cerebral Cortex | 1 | 2017 | 485 | 0.400 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2013 | 35 | 0.380 |
Why?
| | NFATC Transcription Factors | 4 | 2009 | 93 | 0.380 |
Why?
| | Antigens, Fungal | 3 | 2009 | 28 | 0.380 |
Why?
| | Immunologic Memory | 3 | 2016 | 369 | 0.370 |
Why?
| | Erythroid Cells | 1 | 2012 | 8 | 0.360 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 5 | 2014 | 66 | 0.360 |
Why?
| | Disease Models, Animal | 5 | 2020 | 4580 | 0.350 |
Why?
| | beta-Glucans | 1 | 2011 | 16 | 0.340 |
Why?
| | Spleen | 2 | 2012 | 503 | 0.330 |
Why?
| | Tumor Microenvironment | 4 | 2026 | 747 | 0.320 |
Why?
| | Biopsy | 1 | 2013 | 1075 | 0.300 |
Why?
| | Lipid Metabolism | 1 | 2013 | 533 | 0.290 |
Why?
| | Neurons | 2 | 2020 | 1668 | 0.290 |
Why?
| | Cell Line, Tumor | 5 | 2026 | 3545 | 0.290 |
Why?
| | T-Lymphocytes | 3 | 2019 | 2012 | 0.290 |
Why?
| | Th2 Cells | 5 | 2012 | 179 | 0.290 |
Why?
| | Epithelial Cells | 3 | 2022 | 1119 | 0.290 |
Why?
| | Cell Cycle | 2 | 2009 | 595 | 0.280 |
Why?
| | Multiple Sclerosis | 2 | 2013 | 435 | 0.280 |
Why?
| | Mucins | 1 | 2009 | 75 | 0.280 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2009 | 55 | 0.280 |
Why?
| | Respiratory Mucosa | 1 | 2011 | 323 | 0.270 |
Why?
| | Neoplasm Metastasis | 4 | 2025 | 693 | 0.270 |
Why?
| | Cell Nucleus | 3 | 2020 | 584 | 0.270 |
Why?
| | ADAM Proteins | 1 | 2008 | 65 | 0.270 |
Why?
| | Respiratory System | 1 | 2009 | 150 | 0.270 |
Why?
| | Lung Diseases | 2 | 2012 | 787 | 0.270 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2008 | 84 | 0.260 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2008 | 80 | 0.260 |
Why?
| | Wounds and Injuries | 1 | 2016 | 959 | 0.260 |
Why?
| | Antibody Formation | 1 | 2009 | 290 | 0.260 |
Why?
| | RNA, Small Interfering | 2 | 2020 | 633 | 0.260 |
Why?
| | Humans | 30 | 2026 | 146342 | 0.250 |
Why?
| | Signal Transduction | 8 | 2025 | 5246 | 0.250 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 992 | 0.240 |
Why?
| | Cells, Cultured | 8 | 2020 | 4118 | 0.230 |
Why?
| | Interleukin-2 | 1 | 2007 | 434 | 0.230 |
Why?
| | RNA Editing | 1 | 2025 | 26 | 0.230 |
Why?
| | Th17 Cells | 2 | 2020 | 103 | 0.230 |
Why?
| | Mice, SCID | 2 | 2021 | 360 | 0.230 |
Why?
| | Female | 19 | 2025 | 79499 | 0.220 |
Why?
| | Membrane Proteins | 2 | 2010 | 1130 | 0.220 |
Why?
| | Adenosine Deaminase | 1 | 2025 | 45 | 0.220 |
Why?
| | Ovalbumin | 2 | 2024 | 187 | 0.220 |
Why?
| | V(D)J Recombination | 1 | 2025 | 8 | 0.220 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 178 | 0.220 |
Why?
| | Paclitaxel | 1 | 2006 | 260 | 0.220 |
Why?
| | Mice, Transgenic | 10 | 2014 | 2134 | 0.210 |
Why?
| | Disease Progression | 2 | 2026 | 2867 | 0.210 |
Why?
| | Pneumonia | 1 | 2010 | 635 | 0.200 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1185 | 0.200 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 106 | 0.200 |
Why?
| | Electron Transport Complex II | 1 | 2023 | 27 | 0.200 |
Why?
| | Acute Disease | 1 | 2026 | 1038 | 0.190 |
Why?
| | Models, Immunological | 2 | 2013 | 100 | 0.190 |
Why?
| | Calcium | 2 | 2021 | 1181 | 0.190 |
Why?
| | Acetaminophen | 1 | 2025 | 268 | 0.180 |
Why?
| | In Vitro Techniques | 2 | 2021 | 1041 | 0.180 |
Why?
| | Interferon-gamma | 4 | 2016 | 781 | 0.180 |
Why?
| | Natural Killer T-Cells | 2 | 2013 | 71 | 0.170 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 271 | 0.170 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 983 | 0.170 |
Why?
| | Th1 Cells | 4 | 2012 | 139 | 0.170 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 465 | 0.170 |
Why?
| | Drug Resistance, Multiple | 1 | 2021 | 25 | 0.170 |
Why?
| | Receptors, Interleukin-21 | 2 | 2012 | 2 | 0.160 |
Why?
| | Influenza, Human | 1 | 2026 | 640 | 0.160 |
Why?
| | Biomimetic Materials | 1 | 2021 | 78 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2009 | 677 | 0.160 |
Why?
| | Datasets as Topic | 1 | 2020 | 120 | 0.150 |
Why?
| | Neutrophils | 2 | 2020 | 1133 | 0.150 |
Why?
| | Sonication | 1 | 2019 | 12 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2020 | 173 | 0.150 |
Why?
| | Pulmonary Fibrosis | 2 | 2022 | 395 | 0.150 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 598 | 0.150 |
Why?
| | Hepatocytes | 1 | 2020 | 224 | 0.140 |
Why?
| | Diet, High-Fat | 1 | 2020 | 267 | 0.140 |
Why?
| | Doxorubicin | 1 | 2021 | 416 | 0.140 |
Why?
| | Receptors, Histamine H1 | 2 | 2008 | 3 | 0.140 |
Why?
| | Male | 14 | 2025 | 73396 | 0.140 |
Why?
| | Lymphocyte Subsets | 2 | 2016 | 79 | 0.130 |
Why?
| | Oxygen Consumption | 1 | 2021 | 721 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2026 | 874 | 0.130 |
Why?
| | Septal Nuclei | 1 | 2018 | 24 | 0.130 |
Why?
| | Cell Survival | 3 | 2010 | 1105 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 486 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2025 | 2675 | 0.120 |
Why?
| | Leukocyte Common Antigens | 3 | 2013 | 86 | 0.120 |
Why?
| | Cell Proliferation | 4 | 2025 | 2502 | 0.120 |
Why?
| | Histones | 2 | 2023 | 670 | 0.120 |
Why?
| | Immunoglobulin Class Switching | 1 | 2016 | 21 | 0.120 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1075 | 0.120 |
Why?
| | Autoimmunity | 2 | 2014 | 925 | 0.120 |
Why?
| | Autoimmune Diseases | 2 | 2012 | 467 | 0.120 |
Why?
| | Transcriptional Activation | 2 | 2009 | 369 | 0.120 |
Why?
| | Hypersensitivity | 2 | 2009 | 253 | 0.120 |
Why?
| | Animals, Newborn | 3 | 2020 | 888 | 0.120 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 212 | 0.110 |
Why?
| | Threonine-tRNA Ligase | 1 | 2014 | 5 | 0.110 |
Why?
| | Tumor Cells, Cultured | 1 | 2016 | 882 | 0.100 |
Why?
| | Adipose Tissue, White | 1 | 2014 | 43 | 0.100 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 52 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 7 | 0.100 |
Why?
| | Adipose Tissue, Brown | 1 | 2014 | 60 | 0.100 |
Why?
| | Nanoparticles | 1 | 2020 | 523 | 0.100 |
Why?
| | Antigens, CD1d | 1 | 2013 | 69 | 0.100 |
Why?
| | Cachexia | 1 | 2014 | 74 | 0.100 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 612 | 0.100 |
Why?
| | Rotenone | 1 | 2013 | 21 | 0.090 |
Why?
| | Brain | 2 | 2020 | 2991 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 75 | 0.090 |
Why?
| | Intracellular Membranes | 1 | 2013 | 76 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 474 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 610 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2013 | 120 | 0.090 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2013 | 116 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2025 | 3034 | 0.090 |
Why?
| | Myeloid Cells | 1 | 2014 | 149 | 0.090 |
Why?
| | Metabolome | 1 | 2016 | 390 | 0.090 |
Why?
| | Coxsackievirus Infections | 1 | 2012 | 14 | 0.090 |
Why?
| | Enterovirus B, Human | 1 | 2012 | 25 | 0.090 |
Why?
| | Aging | 3 | 2025 | 1996 | 0.090 |
Why?
| | Mucus | 2 | 2009 | 75 | 0.090 |
Why?
| | Tumor Burden | 1 | 2013 | 326 | 0.090 |
Why?
| | Orchitis | 2 | 2008 | 5 | 0.090 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2011 | 33 | 0.090 |
Why?
| | Hippocampus | 1 | 2017 | 989 | 0.080 |
Why?
| | Protein Modification, Translational | 1 | 2011 | 1 | 0.080 |
Why?
| | Cholesterol | 1 | 2013 | 411 | 0.080 |
Why?
| | Serine | 2 | 2010 | 142 | 0.080 |
Why?
| | Myocarditis | 1 | 2012 | 103 | 0.080 |
Why?
| | Aged | 3 | 2020 | 26432 | 0.080 |
Why?
| | Interleukin-17 | 1 | 2011 | 121 | 0.080 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1242 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 508 | 0.080 |
Why?
| | Fatty Liver | 1 | 2013 | 252 | 0.080 |
Why?
| | Macrophages | 2 | 2016 | 1532 | 0.080 |
Why?
| | Adult | 4 | 2020 | 41087 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2219 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2013 | 430 | 0.070 |
Why?
| | X-Rays | 1 | 2009 | 27 | 0.070 |
Why?
| | Middle Aged | 4 | 2020 | 36619 | 0.070 |
Why?
| | Cell Extracts | 1 | 2009 | 19 | 0.070 |
Why?
| | Interleukin-6 Receptor alpha Subunit | 1 | 2009 | 1 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2018 | 1171 | 0.070 |
Why?
| | Metaplasia | 1 | 2009 | 54 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 186 | 0.070 |
Why?
| | Biomarkers | 2 | 2012 | 4340 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 237 | 0.070 |
Why?
| | ADAM17 Protein | 1 | 2008 | 42 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2009 | 235 | 0.070 |
Why?
| | ADAM10 Protein | 1 | 2008 | 29 | 0.070 |
Why?
| | Antigen Presentation | 2 | 2023 | 209 | 0.070 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 384 | 0.070 |
Why?
| | Ovarian Neoplasms | 1 | 2014 | 604 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2009 | 202 | 0.070 |
Why?
| | Ventricular Myosins | 1 | 2008 | 38 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2014 | 801 | 0.070 |
Why?
| | Immunoglobulin M | 1 | 2009 | 284 | 0.060 |
Why?
| | Receptors, Steroid | 1 | 2007 | 41 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2014 | 1339 | 0.060 |
Why?
| | Asbestos, Serpentine | 1 | 2007 | 5 | 0.060 |
Why?
| | Myosin Heavy Chains | 1 | 2008 | 177 | 0.060 |
Why?
| | Thymus Gland | 1 | 2008 | 310 | 0.060 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2008 | 144 | 0.060 |
Why?
| | DNA Repair | 1 | 2009 | 255 | 0.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 429 | 0.060 |
Why?
| | Protein Kinase C-delta | 1 | 2007 | 45 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 846 | 0.060 |
Why?
| | Flow Cytometry | 3 | 2019 | 1163 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 193 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 616 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2012 | 844 | 0.060 |
Why?
| | beta Catenin | 1 | 2008 | 250 | 0.060 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2007 | 196 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 441 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 30 | 0.060 |
Why?
| | RNA, Double-Stranded | 1 | 2025 | 58 | 0.060 |
Why?
| | Enzyme Activation | 3 | 2014 | 759 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1500 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2008 | 585 | 0.050 |
Why?
| | Diet | 1 | 2013 | 1273 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 170 | 0.050 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 928 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2005 | 149 | 0.050 |
Why?
| | Epitopes | 1 | 2007 | 479 | 0.050 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 96 | 0.050 |
Why?
| | Antibodies, Viral | 1 | 2009 | 689 | 0.050 |
Why?
| | Mice, Nude | 1 | 2026 | 668 | 0.050 |
Why?
| | Models, Biological | 2 | 2008 | 1761 | 0.050 |
Why?
| | Models, Molecular | 2 | 2025 | 1573 | 0.050 |
Why?
| | Protein Domains | 1 | 2025 | 315 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 861 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1463 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2005 | 328 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2006 | 970 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8391 | 0.050 |
Why?
| | Electrons | 1 | 2023 | 81 | 0.050 |
Why?
| | Bacteria | 1 | 2009 | 766 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2023 | 122 | 0.050 |
Why?
| | Methylation | 1 | 2023 | 241 | 0.050 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 373 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2005 | 495 | 0.050 |
Why?
| | Heart Atria | 1 | 2003 | 139 | 0.050 |
Why?
| | Time Factors | 2 | 2018 | 7109 | 0.040 |
Why?
| | Epithelium | 1 | 2022 | 295 | 0.040 |
Why?
| | NF-kappa B | 1 | 2005 | 674 | 0.040 |
Why?
| | Apoptosis | 1 | 2010 | 2439 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1160 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2026 | 1432 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2007 | 2791 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2020 | 167 | 0.030 |
Why?
| | Astrocytes | 1 | 2020 | 229 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1244 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 902 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2003 | 740 | 0.030 |
Why?
| | Myocardium | 1 | 2003 | 948 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 387 | 0.030 |
Why?
| | Microglia | 1 | 2020 | 289 | 0.030 |
Why?
| | DNA Damage | 1 | 2020 | 439 | 0.030 |
Why?
| | Reflex, Startle | 1 | 2018 | 75 | 0.030 |
Why?
| | Prognosis | 1 | 2006 | 4351 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1177 | 0.030 |
Why?
| | Melanoma | 1 | 2023 | 765 | 0.030 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 120 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1468 | 0.030 |
Why?
| | Transcription Factors | 1 | 2003 | 1730 | 0.030 |
Why?
| | Uncoupling Protein 1 | 1 | 2014 | 17 | 0.030 |
Why?
| | Homeostasis | 2 | 2010 | 646 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 562 | 0.030 |
Why?
| | Ion Channels | 1 | 2014 | 128 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 287 | 0.020 |
Why?
| | Cell Line | 2 | 2008 | 2814 | 0.020 |
Why?
| | Mutation | 3 | 2010 | 4093 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 545 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 197 | 0.020 |
Why?
| | MAP Kinase Kinase 6 | 1 | 2011 | 2 | 0.020 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2011 | 6 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1378 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 11821 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 300 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1125 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2011 | 175 | 0.020 |
Why?
| | Hydrocolpos | 1 | 2010 | 5 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 37 | 0.020 |
Why?
| | Limb Deformities, Congenital | 1 | 2010 | 22 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 153 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1224 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 290 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 218 | 0.020 |
Why?
| | Candida albicans | 1 | 2009 | 62 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 366 | 0.020 |
Why?
| | Ca(2+) Mg(2+)-ATPase | 1 | 2008 | 2 | 0.020 |
Why?
| | Propylthiouracil | 1 | 2008 | 6 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2009 | 152 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits | 1 | 2008 | 15 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1031 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 465 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 106 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2014 | 930 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2009 | 119 | 0.020 |
Why?
| | Histamine | 1 | 2007 | 52 | 0.020 |
Why?
| | Liver Diseases | 1 | 2011 | 304 | 0.020 |
Why?
| | Vagina | 1 | 2010 | 202 | 0.020 |
Why?
| | Antigens | 1 | 2009 | 350 | 0.020 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2007 | 54 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2007 | 64 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2009 | 277 | 0.020 |
Why?
| | Arginine | 1 | 2008 | 264 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2009 | 244 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 391 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 443 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 506 | 0.010 |
Why?
| | STAT6 Transcription Factor | 1 | 2005 | 25 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2240 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2008 | 268 | 0.010 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 392 | 0.010 |
Why?
| | Immunity | 1 | 2006 | 141 | 0.010 |
Why?
| | Nippostrongylus | 1 | 2005 | 5 | 0.010 |
Why?
| | Strongylida Infections | 1 | 2005 | 8 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 266 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 242 | 0.010 |
Why?
| | Pre-B Cell Receptors | 1 | 2005 | 1 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2005 | 7 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 134 | 0.010 |
Why?
| | Matrix Metalloproteinases | 1 | 2005 | 95 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1827 | 0.010 |
Why?
| | Retroviridae | 1 | 2005 | 99 | 0.010 |
Why?
| | Luciferases | 1 | 2005 | 153 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 907 | 0.010 |
Why?
| | Chemokines | 1 | 2005 | 217 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 307 | 0.010 |
Why?
| | Influenza A virus | 1 | 2005 | 120 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2005 | 134 | 0.010 |
Why?
| | Cell Membrane | 1 | 2008 | 701 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2005 | 275 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 406 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1512 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 2005 | 185 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1543 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 408 | 0.010 |
Why?
| | Genes, Regulator | 1 | 2003 | 34 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2007 | 481 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1488 | 0.010 |
Why?
| | Troponin T | 1 | 2003 | 63 | 0.010 |
Why?
| | Sarcomeres | 1 | 2003 | 100 | 0.010 |
Why?
| | Antibodies | 1 | 2005 | 400 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2003 | 384 | 0.010 |
Why?
| | Troponin I | 1 | 2003 | 74 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2005 | 511 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2113 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 614 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1309 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2244 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2488 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1432 | 0.010 |
Why?
| | DNA | 1 | 2005 | 1421 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 800 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2003 | 544 | 0.010 |
Why?
|
|
Rincon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|